Bio-Techne Corp. closed fiscal year 2026 with $2.6B in total assets, $478.5M in total liabilities and $2.1B in shareholder equity. This represents an increase of 1.1% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Bio-Techne Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TECH Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B+1.1% | $2.6B-5.4% | $2.7B+2.5% | $2.6B+15.0% | $2.3B+1.4% | $2.3B+11.6% | $2.0B+7.6% | $1.9B+18.3% | $1.6B+2.2% | $1.6B+37.9% | $1.1B+6.2% | $1.1B+23.3% | $862.5M+10.8% | $778.1M+8.2% | $719.3M |
| Total Liabilities | $478.5M-25.1% | $639.1M+0.6% | $635.0M-5.5% | $672.2M+13.3% | $593.0M-15.3% | $700.0M+8.3% | $646.4M-10.1% | $718.8M+39.8% | $514.1M-15.5% | $608.6M+143.1% | $250.3M+15.7% | $216.4M+221.9% | $67.2M+65.8% | $40.6M-9.6% | $44.9M |
| Total Equity | $2.1B+9.9% | $1.9B-7.3% | $2.1B+5.2% | $2.0B+15.6% | $1.7B+8.9% | $1.6B+13.2% | $1.4B+18.5% | $1.2B+8.0% | $1.1B+13.6% | $949.6M+8.0% | $879.3M+3.8% | $846.9M+6.5% | $795.3M+7.8% | $737.5M+9.4% | $674.4M |
TECH Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B+1.1% | $2.6B-3.5% | $2.5B-5.5% | $2.5B-7.7% | $2.6B-5.4% | $2.6B-2.8% | $2.7B-2.2% | $2.7B-0.7% | $2.7B+2.5% | $2.7B+4.7% | $2.7B+15.5% | $2.8B+17.2% |
| Total Liabilities | $478.5M-25.1% | $465.3M-25.7% | $511.7M-13.6% | $560.3M-6.2% | $639.1M+0.6% | $626.2M-11.4% | $591.9M-22.8% | $597.4M-21.2% | $635.0M-5.5% | $706.8M-0.5% | $767.2M+43.1% | $757.6M+26.4% |
| Total Equity | $2.1B+9.9% | $2.1B+3.3% | $2.0B-3.2% | $2.0B-8.1% | $1.9B-7.3% | $2.0B+0.2% | $2.1B+5.9% | $2.1B+7.1% | $2.1B+5.2% | $2.0B+6.6% | $2.0B+7.5% | $2.0B+14.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Bio-Techne Corp. financials
Frequently Asked Questions
What was Bio-Techne Corp.'s total assets in fiscal year 2026?
Bio-Techne Corp. closed fiscal year 2026 with $2.6B in total assets, $478.5M in total liabilities and $2.1B in shareholder equity.
How fast is Bio-Techne Corp.'s total assets growing?
Bio-Techne Corp. (TECH) total assets rose by 1.1% year over year, from $2.6B to $2.6B in fiscal year 2026.
How has Bio-Techne Corp.'s total assets changed over the years?
Across the 15 fiscal years this page covers, Bio-Techne Corp. (TECH) total assets went from $719.3M in fiscal year 2012 to $2.6B in fiscal year 2026.
What was Bio-Techne Corp.'s total assets in the most recent quarter?
Bio-Techne Corp. (TECH) reported $2.6B in total assets in Q4 2026. This represents an increase of 1.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Bio-Techne Corp. (TECH) reported on that line in every period on record.